Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components

Overview

Journal Microorganisms

Specialty Microbiology

Date 2021 Sep 28

PMID 34576690

Citations 9

Authors

Mansi Srivastava

Dwight Hall

Okiemute Beatrice Omoru

Hunter Mathias Gill

Sarah Smith

Sarath Chandra Janga

Affiliations

Soon will be listed here.

Abstract

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its rapid evolution has led to a global health crisis. Increasing mutations across the SARS-CoV-2 genome have severely impacted the development of effective therapeutics and vaccines to combat the virus. However, the new SARS-CoV-2 variants and their evolutionary characteristics are not fully understood. Host cellular components such as the ACE2 receptor, RNA-binding proteins (RBPs), microRNAs, small nuclear RNA (snRNA), 18s rRNA, and the 7SL RNA component of the signal recognition particle (SRP) interact with various structural and non-structural proteins of the SARS-CoV-2. Several of these viral proteins are currently being examined for designing antiviral therapeutics. In this review, we discuss current advances in our understanding of various host cellular components targeted by the virus during SARS-CoV-2 infection. We also summarize the mutations across the SARS-CoV-2 genome that directs the evolution of new viral strains. Considering coronaviruses are rapidly evolving in humans, this enables them to escape therapeutic therapies and vaccine-induced immunity. In order to understand the virus's evolution, it is essential to study its mutational patterns and their impact on host cellular machinery. Finally, we present a comprehensive survey of currently available databases and tools to study viral-host interactions that stand as crucial resources for developing novel therapeutic strategies for combating SARS-CoV-2 infection.

Citing Articles

A practically efficient algorithm for identifying critical control proteins in directed probabilistic biological networks.

Tokuhara Y, Akutsu T, Schwartz J, Nacher J NPJ Syst Biol Appl. 2024; 10(1):87.

PMID: 39134558 PMC: 11319667. DOI: 10.1038/s41540-024-00411-y.

Sequence Analysis of Hot Spot Regions of Spike and RNA-dependent-RNA polymerase (RdRp) Genes of SARS-CoV-2 in Kerman, Iran.

Arefinia N, Yaghobi R, Ramezani A, Sarvari J Mediterr J Hematol Infect Dis. 2023; 15(1):e2023042.

PMID: 37435034 PMC: 10332355. DOI: 10.4084/MJHID.2023.042.

A comprehensive analysis of gene expression profiling data in COVID-19 patients for discovery of specific and differential blood biomarker signatures.

Momeni M, Rashidifar M, Balam F, Roointan A, Gholaminejad A Sci Rep. 2023; 13(1):5599.

PMID: 37019895 PMC: 10075178. DOI: 10.1038/s41598-023-32268-2.

Experimental and computational methods for studying the dynamics of RNA-RNA interactions in SARS-COV2 genomes.

Srivastava M, Dukeshire M, Mir Q, Omoru O, Manzourolajdad A, Janga S Brief Funct Genomics. 2023; 23(1):46-54.

PMID: 36752040 PMC: 10799312. DOI: 10.1093/bfgp/elac050.

Host tRNA-Derived RNAs Target the 3'Untranslated Region of SARS-CoV-2.

Hendrickson E, Ericson M, Bemis L Pathogens. 2022; 11(12).

PMID: 36558813 PMC: 9786188. DOI: 10.3390/pathogens11121479.

References

Jafarinejad-Farsangi S, Jazi M, Rostamzadeh F, Hadizadeh M . High affinity of host human microRNAs to SARS-CoV-2 genome: An in silico analysis. Noncoding RNA Res. 2020; 5(4):222-231. PMC: 7680021. DOI: 10.1016/j.ncrna.2020.11.005. View

Sacar Demirci M, Adan A . Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection. PeerJ. 2020; 8:e9369. PMC: 7278893. DOI: 10.7717/peerj.9369. View

Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K . SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020; 65(12):1075-1082. PMC: 7375454. DOI: 10.1038/s10038-020-0808-9. View

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

van Dorp L, Acman M, Richard D, Shaw L, Ford C, Ormond L . Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020; 83:104351. PMC: 7199730. DOI: 10.1016/j.meegid.2020.104351. View

Flynn R, Belk J, Qi Y, Yasumoto Y, Wei J, Alfajaro M . Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions. Cell. 2021; 184(9):2394-2411.e16. PMC: 7951565. DOI: 10.1016/j.cell.2021.03.012. View

Phan T . Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020; 81:104260. PMC: 7106203. DOI: 10.1016/j.meegid.2020.104260. View

Henne W, Kent H, Ford M, Hegde B, Daumke O, Butler P . Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature. Structure. 2007; 15(7):839-52. DOI: 10.1016/j.str.2007.05.002. View

Jackson C, Zhang L, Farzan M, Choe H . Functional importance of the D614G mutation in the SARS-CoV-2 spike protein. Biochem Biophys Res Commun. 2020; 538:108-115. PMC: 7664360. DOI: 10.1016/j.bbrc.2020.11.026. View

10.

Sa Ribero M, Jouvenet N, Dreux M, Nisole S . Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog. 2020; 16(7):e1008737. PMC: 7390284. DOI: 10.1371/journal.ppat.1008737. View

11.

Garcia-Beltran W, Lam E, St Denis K, Nitido A, Garcia Z, Hauser B . Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021; 184(9):2372-2383.e9. PMC: 7953441. DOI: 10.1016/j.cell.2021.03.013. View

12.

Huang X, Wei F, Hu L, Wen L, Chen K . Epidemiology and Clinical Characteristics of COVID-19. Arch Iran Med. 2020; 23(4):268-271. DOI: 10.34172/aim.2020.09. View

13.

Stadio A, Costantini C, Renga G, Pariano M, Ricci G, Romani L . The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19. Life (Basel). 2020; 10(12). PMC: 7763594. DOI: 10.3390/life10120345. View

14.

Auvinen E . Diagnostic and Prognostic Value of MicroRNA in Viral Diseases. Mol Diagn Ther. 2016; 21(1):45-57. DOI: 10.1007/s40291-016-0236-x. View

15.

Kendall E, Bynoe M, Tyrrell D . Virus isolations from common colds occurring in a residential school. Br Med J. 1962; 2(5297):82-6. PMC: 1925312. DOI: 10.1136/bmj.2.5297.82. View

16.

Pierce J, Simion V, Icli B, Perez-Cremades D, Cheng H, Feinberg M . Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs. Genes (Basel). 2020; 11(11). PMC: 7696723. DOI: 10.3390/genes11111354. View

17.

Thoreen C . The molecular basis of mTORC1-regulated translation. Biochem Soc Trans. 2017; 45(1):213-221. DOI: 10.1042/BST20160072. View

18.

Vandelli A, Monti M, Milanetti E, Armaos A, Rupert J, Zacco E . Structural analysis of SARS-CoV-2 genome and predictions of the human interactome. Nucleic Acids Res. 2020; 48(20):11270-11283. PMC: 7672441. DOI: 10.1093/nar/gkaa864. View

19.

Edara V, Pinsky B, Suthar M, Lai L, Davis-Gardner M, Floyd K . Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants. N Engl J Med. 2021; 385(7):664-666. PMC: 8279090. DOI: 10.1056/NEJMc2107799. View

20.

La Scola B, Lavrard P, Fournier P, Colson P, Lacoste A, Raoult D . SARS-CoV-2 variant from India to Marseille: The still active role of ports in the introduction of epidemics. Travel Med Infect Dis. 2021; 42:102085. PMC: 8139435. DOI: 10.1016/j.tmaid.2021.102085. View